These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20485910)

  • 1. Bisphosphonates in the treatment of metabolic bone diseases.
    Arantes HP; Silva AG; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):206-12. PubMed ID: 20485910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety considerations with bisphosphonates for the treatment of osteoporosis.
    Strampel W; Emkey R; Civitelli R
    Drug Saf; 2007; 30(9):755-63. PubMed ID: 17722968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bisphosphonates in osteoporosis therapy. Standards and perspectives].
    Reinsdorf S; Habermann B; Hochmuth K; Kurth AA
    Orthopade; 2007 Feb; 36(2):110-7. PubMed ID: 17252258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates and metabolic bone disease in the ICU.
    Hollander JM; Mechanick JI
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):190-5. PubMed ID: 19209471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates and osteonecrosis: potential treatment or serious complication?
    Goytia RN; Salama A; Khanuja HS
    Orthop Clin North Am; 2009 Apr; 40(2):223-34. PubMed ID: 19358907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates.
    McClung M
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):735-44. PubMed ID: 17117298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Questions and answers about bisphosphonates].
    Letonturier P
    Presse Med; 2007 Mar; 36(3 Pt 1):440. PubMed ID: 17436449
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term use of bisphosphonates in osteoporosis.
    Watts NB; Diab DL
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis.
    Zahrowski JJ
    Am J Orthod Dentofacial Orthop; 2009 Mar; 135(3):361-74. PubMed ID: 19268836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates.
    Reid IR
    Skeletal Radiol; 2007 Aug; 36(8):711-4. PubMed ID: 17340165
    [No Abstract]   [Full Text] [Related]  

  • 13. [Innovation of bisphosphonates for improvement of adherence.].
    Takeuchi Y
    Clin Calcium; 2017; 27(2):197-202. PubMed ID: 28123121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of bisphosphonates does not contraindicate orthodontic and other types of treatment!
    Consolaro A
    Dental Press J Orthod; 2014; 19(4):18-26. PubMed ID: 25279517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic bone diseases: benefits and risks of the treatment].
    Rizzoli R
    Rev Med Suisse; 2009 Jun; 5(207):1299-300. PubMed ID: 19626928
    [No Abstract]   [Full Text] [Related]  

  • 16. Bisphosphonate-related osteonecrosis of the jaw: an overview.
    Ruggiero SL
    Ann N Y Acad Sci; 2011 Feb; 1218():38-46. PubMed ID: 20946580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
    Lee J
    J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonates for osteoporosis in nonmetastatic prostate cancer patients receiving androgen-deprivation therapy: a systematic review and meta-analysis.
    Ding H; Yang L; Du W; Teng Y; Fu SJ; Tao Y; Lu JZ; Wang ZP
    Asian Pac J Cancer Prev; 2013; 14(5):3337-43. PubMed ID: 23803126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates for the prevention and treatment of osteoporosis.
    Maraka S; Kennel KA
    BMJ; 2015 Sep; 351():h3783. PubMed ID: 26333528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.